Foresee Pharmaceuticals Co., Ltd.

This study is testing a long-acting injection called FP-001 to safely and effectively pause early puberty in children. Kids aged 2-9 with a confirmed diagnosis will receive two injections, six months apart. Researchers will check if the treatment successfully slows down the physi…